Independent Advisor Alliance Has $2.44 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Independent Advisor Alliance grew its stake in shares of The Clorox Company (NYSE:CLX) by 0.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,008 shares of the company’s stock after purchasing an additional 104 shares during the period. Independent Advisor Alliance’s holdings in Clorox were worth $2,438,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of CLX. State Street Corp boosted its position in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after buying an additional 245,525 shares during the period. Mizuho Securities USA LLC lifted its stake in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after purchasing an additional 33,970 shares during the period. Stifel Financial Corp grew its holdings in shares of Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after acquiring an additional 37,967 shares in the last quarter. Finally, Amundi grew its stake in Clorox by 42.6% in the fourth quarter. Amundi now owns 1,032,283 shares of the company’s stock valued at $165,816,000 after purchasing an additional 308,234 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of NYSE:CLX opened at $146.79 on Friday. The company has a market cap of $18.08 billion, a price-to-earnings ratio of 40.11, a PEG ratio of 2.62 and a beta of 0.45. The business has a 50 day moving average price of $154.51 and a 200 day moving average price of $160.23. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the business earned $2.16 earnings per share. Research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.32%. The ex-dividend date is Wednesday, April 23rd. Clorox’s payout ratio is presently 133.33%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CLX. JPMorgan Chase & Co. lifted their price target on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Barclays increased their price target on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Evercore ISI lifted their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, DA Davidson lowered their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 5th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, Clorox presently has an average rating of “Hold” and an average price target of $159.62.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.